CU was found to be neuroprotective in the MPTP model of Parkinson's disease (Ojha et al., 2012) by inhibiting the generation of pro-inflammatory cytokines through the prevention of NF-κB traslocation into the nucleus (Karunaweera et al., 2015). Here, NFKB1 is linked to Parkinson disease.